MorphBio

Our partner Dr. Ronan O'Kennedy has published an innovative technique for growth media & feed optimization in the March 2016 issue of Bioprocess International.

This paper will be of interest to those involved in mammalian cell culture & microbial bioprocess development.The detailed composition of over 200 biological additives has been captured in a database are analysed using multivariate modelling.

http://www.bioprocessintl.com/upstream-processing/biochemicals-raw-materials/multivariate-analysis-of-biological-additives-for-growth-media-and-feeds/

Multivariate Analysis of Biological Additives for Growth Media and Feeds - BioProcess International To analyze animal component free biological additives for growth media, a principal-component analysis for modeling variance

“These systems biology models covering metabolic and secretory pathways will eventually allow us to understand how everything functions together. We will be able to learn what governs the different protein production capabilities for protein production in cell lines and clones.”

http://www.genengnews.com/gen-articles/systems-biology-finally-cho-ready/5667/

Systems Biology Finally CHO-Ready | GEN Magazine Articles | GEN

Congrats and all the best !:) https://t.co/dmxJEMl4wm https://t.co/cpC7QSsc4b

- Personalize My Medicine Welcome to Personalize My Medicine Personalize My Medicine was created to address the growing need for a platform for medical innovation that places people and patients at the center. Our aim is to integrate disciplines and to research, inform, and facilitate advancements in healthcare for anyone wh…

The first biotech accelerator in Italy has been launched!

http://www.european-biotechnology-news.com/news/news/2015-04/italys-first-biotech-accelerator.html

Italy’s first biotech accelerator The first Italian accelerator specifically for biotech projects has been launched with help from Sofinnova Partners. The plan of BiovelocITA: to help Italy grow into one of Europe’s strongest biotech markets.

Microsoft has released tools that allow bioinformatics researchers to work on genome data sets securely to protect privacy.

http://www.itnews.com.au/news/microsoft-releases-encryption-tech-for-bioinformatics-411843

Microsoft releases encryption tech for bioinformatics Allows researchers to work on data securely.

'Improving manufacturing efficiency and quality are high priorities, and new technologies—including continuous manufacturing and data analytics—can help the pharmaceutical "facility of the future".'

http://www.pharmtech.com/giving-boost-facility-future

Giving a Boost to the Facility of the Future Employing continuous manufacturing and data analytics will help improve the efficiency of pharmaceutical manufacturing in the facility of the future.

What are the key challenges during the production of biosimilar?

http://www.genengnews.com/gen-articles/biosimilar-manufacturing-challenges/5625/

Biosimilar Manufacturing Challenges | GEN Magazine Articles | GEN

AstraZeneca has agreed to buy ZS Pharma, the US biotech company, for $2.7bn in cash.

http://www.bizjournals.com/sanfrancisco/blog/biotech/2015/11/astrazeneca-zs-buy-biotech-bay-area-2-billion-azn.html

AstraZeneca to buy Bay Area biotech ZS Pharma for $2.7 billion - San Francisco Business Times The deal includes a new drug candidate with potential sales projected at more than $1 billion.

'Healthcare today is like a repairman who is trying to constantly fix a leaky roof by putting a bucket under the leak. Healthcare tomorrow is like using a scanning device to find the weakest part of the roof and reinforce it before the leak begins.'

http://singularityhub.com/2015/09/28/a-genomics-revolution-evolution-by-natural-selection-to-evolution-by-intelligent-direction/

A Genomics Revolution: Evolution by Natural Selection to Evolution by Intelligent Direction -... Humanity is moving from evolution by natural selection (Darwinism) to evolution by intelligent direction. For most of human history, our average age was only about 26 years old. We would... read more

"What's exciting to me is that if we can make antibodies against this toxin and include them in a vaccine, we could potentially prevent a dengue infection from progressing to the more severe symptoms," noted Dr. Beatty.

http://www.genengnews.com/gen-news-highlights/dengue-hemorrhagic-shock-protein-identified/81251721/

Dengue Hemorrhagic Shock Protein Identified | GEN News Highlights | GEN New findings provide promising target for drug and vaccine research.

'If the collaboration goes as planned, AstraZeneca will gain a system that can pull in data from a range of sources and pump out tips for how to treat a particular patient.'

http://www.fiercebiotechit.com/story/astrazeneca-commits-18m-clinical-trial-bioinformatics-collaboration/2015-09-10

AstraZeneca commits $18M to clinical trial bioinformatics collaboration AstraZeneca is pumping £11.5 million ($17.7 million) into a push to develop bioinformatics infrastructure to match its oncology ambitions. The money will finance a 5-year collaboration with the University of Manchester, during which AstraZeneca hopes to establish a bioinformatics system to match can…